Independent Biotechnology Companies
- The following is a list of the top 25 independent biotechnology companies listed on a stock exchange ranked by Market Capitalization in Q2 of 2012. It additionally details their market capitalization in Q2 of the previous year (2011), from which the change in value over the year can be calculated.
- Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups - such as Genentech (owned by Roche), Genzyme (Sanofi), or MedImmune (AstraZeneca). It should be viewed as an update and complementary to the previous table below.
| Rank 2012 | Company | Country | Market Cap in 2012 | Market Cap in 2011 | % Change over year (Q2-Q2) | Website |
|---|---|---|---|---|---|---|
| 1 | Novo Nordisk | Denmark | 76.92 | 60.09 | 28.0% | novonordisk.com |
| 2 | Amgen | USA | 60.09 | 49.72 | 20.9% | amgen.com |
| 3 | Gilead Sciences | USA | 40.16 | 32.68 | 28.5% | gilead.com |
| 4 | Biogen Idec | USA | 34.26 | 25.6 | 28.5% | biogenidec.com |
| 5 | Teva Pharmaceutical Industries | Israel | 34.23 | 42.96 | -20.3% | tevapharm.com |
| 6 | Baxter International | USA | 32.27 | 33.36 | -3.3% | baxter.com |
| 7 | Celgene | USA | 28.38 | 27.52 | 3.1% | celgene.com |
| 8 | Merck KGaA | Germany | 21.16 | 20.14 | 5.1% | merckgroup.com |
| 9 | CSL | Australia | 21.11 | 18.33 | 15.2% | csl.com.au |
| 10 | Alexion Pharmaceuticals | USA | 18.85 | 10.48 | 79.9% | alxn.com |
| 11 | Vertex Pharmaceuticals | USA | 10.64 | 10.79 | -1.4% | vrtx.com |
| 12 | Regeneron | USA | 11.3 | 5.09 | 122.0% | regeneron.com |
| 13 | Forest Laboratories | USA | 8.87 | 9.09 | -2.4% | frx.com |
| 14 | UCB | Belgium | 8.77 | 6.84 | 28.2% | ucb.com |
| 15 | Élan | Ireland | 8.63 | 6.67 | 29.4% | elan.com |
| 16 | BioMarin Pharmaceutical | USA | 5.35 | 3.32 | 61.1% | biomarinpharm.com |
| 17 | Dr. Reddy's Laboratories | India | 5.35 | 5.03 | 6.4% | drreddys.com |
| 18 | Amylin Pharmaceuticals § | USA | 5.06 | 1.74 | 190.8% | amylin.com |
| 19 | Onyx Pharmaceuticals | USA | 5.06 | 2.1 | 141.0% | onyx.com |
| 20 | Actelion | Switzerland | 4.65 | 5.02 | -7.4% | actelion.com |
| 21 | Warner Chilcott | Ireland | 4.49 | 5.69 | -21.1% | wcrx.com |
| 22 | Ranbaxy Laboratories | India | 3.71 | 4.08 | -9.1% | ranbaxy.com |
| 23 | Medivation | USA | 3.65 | 0.683 | 433.4% | medivation.com |
| 24 | ARIAD Pharmaceuticals | USA | 3.18 | 1.58 | 101.3% | ariad.com |
| 25 | Seattle Genetics | USA | 2.92 | 1.89 | 54.5% | seagen.com |
§ - Acquired by Bristol-Myers Squibb in a $7 billion deal completed Aug 8 2012 (therefore no longer independent in this list going forward).
NOTE: Market Cap is an indication of the perceived value of the company (&/or its technology) and not necessarily a measure of its size, sales or number of employees; it is indicative of both current and future scale and profitability of the company. The year-on-year change in its value is indicative of the (real or perceived) performance or progress of that company over that year.
Read more about this topic: List Of Biotechnology Companies
Famous quotes containing the words independent and/or companies:
“We are independent of the change we detect. The longer the lever, the less perceptible its motion. It is the slowest pulsation which is the most vital. The hero then will know how to wait, as well as to make haste. All good abides with him who waiteth wisely; we shall sooner overtake the dawn by remaining here than by hurrying over the hills of the west.”
—Henry David Thoreau (1817–1862)
“Socialite women meet socialite men and mate and breed socialite children so that we can fund small opera companies and ballet troupes because there is no government subsidy.”
—Sugar Rautbord, U.S. socialite fund-raiser and self-described “trash” novelist. As quoted in The Great Divide, book 2, section 7, by Studs Terkel (1988)